Reduction of Alzheimer’s Disease Amyloid-β in Plasma by Hemodialysis and Its Relation to Cognitive Functions

Publisher： Karger

E-ISSN： 1421-9735|32|1|57-62

ISSN： 0253-5068

Source： Blood Purification, Vol.32, Iss.1, 2011-02, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kimura’s Disease in a Chronic Hemodialysis Patient

By  

American Journal of Nephrology, Vol. 21, Iss. 1, 2001-03 ,pp. : 47-50

Karger

Access to resources Recommend Favorite

Crohn’s Disease with Amyloid A Amyloidosis and Nephrotic Syndrome

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 123-124

Karger

Access to resources Recommend Favorite

New Acetylcholinesterase Inhibitor (Donepezil) Treatment for Alzheimer’s Disease in a Chronic Dialysis Patient

By  

Nephron, Vol. 91, Iss. 2, 2002-06 ,pp. : 330-332

Karger

Access to resources Recommend Favorite

Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients

By  

Blood Purification, Vol. 43, Iss. 1-3, 2017-01 ,pp. : 210-217

Karger

Access to resources Recommend Favorite

Ultrapure Dialysate Reduces Plasma Levels of β2-Microglobulin and Pentosidine in Hemodialysis Patients

By  

Blood Purification, Vol. 23, Iss. 4, 2005-10 ,pp. : 311-316

Karger

Access to resources Recommend Favorite